1-3 of 3
Miguel Angel Herrera-Rojas, MD
Close
Sort by
Journal Articles

Ocular Graft-Versus Host Disease Prevention with Topical Cyclosporine in Non-Myeloablative Allogeneic Stem Cell Transplant

Rosa Elena Lozano-Morales, MD, Alberto Vázquez-Mellado de Larracoechea, Olga Cantu-Rodriguez, MD, Juan Luis Gonzalez-Treviño, Perla Rocío Colunga-Pedraza, MD, Miguel Angel Herrera-Rojas, MD, Monica Sánchez-Cárdenas, David Martínez-Garza, Daniela Michelle Pérez-Garza, David Gomez-Almaguer, MD
Journal: Blood
Blood (2016) 128 (22): 4569.
https://doi.org/10.1182/blood.V128.22.4569.4569
Published: 2016
Journal Articles

Autologus Hematopoietic Stem Cell Transplant in Type 1 Diabetes Mellitus in a Nonmyeloablative and Outpatient Setting

Olga Graciela Cantú-Rodríguez, MD, Fernando Lavalle-Gonzalez, MD, Miguel Angel Herrera-Rojas, MD, Cesar H Gutiérrez-Aguirre, MD, Consuelo Mancías-Guerra, MD, Jose Carlos Jaime-Pérez, MD, Oscar Gonzalez-Llano, MD, Alfonso Zapata-Garrido, MD, Jesus Zacarias Villarreal-Perez, MD, David Gomez-Almaguer, MD
Journal: Blood
Blood (2014) 124 (21): 1191.
https://doi.org/10.1182/blood.V124.21.1191.1191
Published: 2014
Journal Articles

Eltrombopag and High-Dose Dexamethasone As First Line Treatment For ITP

David Gomez-Almaguer, MD, Miguel Angel Herrera-Rojas, MD, Andres Gomez-de Leon, MD, Olga Graciela Cantú-Rodríguez, MD, Cesar H Gutiérrez-Aguirre, MD, Jose Carlos Jaime-Pérez, MD, Luz C. Tarin-Arzaga, MD, Guillermo J. Ruiz-Arguelles, MD, FRCP (Glasg), MACP, Jesus Hernandez-Reyes, MD
Journal: Blood
Blood (2013) 122 (21): 3544.
https://doi.org/10.1182/blood.V122.21.3544.3544
Published: 2013